InMed and the laboratory of Dr. Vikramaditya Yadav at the University of British Columbia collaborate on a proprietary biosynthesis technology to produce bioidentical, high purity, high grade cannabinoids. The host selected is E.coli. In this video, Dr. Yadav talks how an E.coli-based system is uniquely suited for producing cannabinoids.
InMed Presents at the 2025 Life Sciences Investor Forum
Video Replay Now Available: InMed’s CEO, Eric A. Adams, presents at the 2025 Life Sciences Investor Forum. In the presentation, which was originally published on
October 14, 2025
